WHO ICTRP trial
Effect of Busulfan in left ventricular global lingitudinal strain
IRCT20191230045950N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20191230045950N1 |
|---|---|
| Public title | Effect of Busulfan in left ventricular global lingitudinal strain |
| Scientific title | Assessment of left ventricular function by global longitudinal strain to detect subclinical Cardiomyopathy early after Busulfan therapy in patients undergoing bone marrow allogeneic transplantation |
| Primary sponsor | Shahid Beheshti University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Cardiomyopathy. Cardiomyopathy |
| Interventions | Intervention group:Echocardiograghy was done for Pateints undergoing bone marrow transplantation at the begining of the study and then 7 days after Busulfan therapy .Busulfan dose was 0.8 mg/kg with intravenus infusion during two hours… |
| Registration date | Jan 18, 2020 |
| Target size | 30 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: